CRON Stock Chart & Stats
$3.51
$0.07(2.55%)
At close: 4:00 PM EDT
$3.51
$0.07(2.55%)
Day’s Range― - ―
52-Week Range$2.28 - $3.61
Previous Close$2.02
Volume1.22M
Average Volume (3M)1.50M
Market Cap
$1.20B
Enterprise Value$410.50
Total Cash (Recent Filing)$797.02M
Total Debt (Recent Filing)$1.29M
Price to Earnings (P/E)17.3
Beta0.55
Next Earnings
Nov 11, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.19
Shares Outstanding368,412,870
10 Day Avg. Volume1,513,478
30 Day Avg. Volume1,495,871
Financial Highlights & Ratios
PEG Ratio0.83
Price to Book (P/B)0.92
Price to Sales (P/S)6.74
P/FCF Ratio6.63K
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$3.40Price Target Upside-3.10% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.1
Revenue Forecast (FY)$142.82M
Bulls Say, Bears Say
Bulls Say
Revenue And Brand GrowthStrong revenue growth across Canada, Israel and international markets indicates expanding demand and distribution. Spinach’s above-market performance and leading category shares provide brand strength that can support durable shelf space and pricing.
Conservative Balance SheetMinimal leverage and substantial liquidity reduce refinancing risk and give Cronos flexibility to fund product development, international expansion, acquisitions or buybacks. This financial resilience is particularly valuable in a regulated, capital-intensive industry.
Improving Cash GenerationThe shift from negative operating and free cash flow in 2021–2023 to positive TTM generation suggests improving operating leverage and cash conversion. Sustained cash generation would strengthen self-funded growth and reduce dependence on external capital.
Bears Say
Unproven Profitability DurabilityCronos has made meaningful progress, but persistent net losses and a history of operating losses show that the turnaround is not yet fully established. Inconsistent profitability could limit reinvestment capacity and make results more sensitive to mix and cost changes.
Margin VolatilityReliance on seasonal growing conditions, higher-ASP markets and vape mix makes reported margins less predictable. Variability can complicate planning and weaken confidence that recent gross-margin expansion will persist across different quarters.
Regulatory And Expansion Execution RiskRegulatory scrutiny in Israel could disrupt an important growth market, while delayed Dutch clearance may postpone expected international expansion. These matters create execution uncertainty and could defer the benefits of geographic diversification.
Cronos Group News
CRON FAQ
What was Cronos Group’s price range in the past 12 months?
Cronos Group lowest stock price was $2.28 and its highest was $3.61 in the past 12 months.
What is Cronos Group’s market cap?
Cronos Group’s market cap is $1.20B.
When is Cronos Group’s upcoming earnings report date?
Cronos Group’s upcoming earnings report date is Nov 11, 2026 which is in 66 days.
How were Cronos Group’s earnings last quarter?
Cronos Group released its earnings results on Aug 06, 2026. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.08.
Is Cronos Group overvalued?
According to Wall Street analysts Cronos Group’s price is currently Overvalued.
Does Cronos Group pay dividends?
Cronos Group does not currently pay dividends.
What is Cronos Group’s EPS estimate?
Cronos Group’s EPS estimate is 0.03.
How many shares outstanding does Cronos Group have?
Cronos Group has 368,412,870 shares outstanding.
What happened to Cronos Group’s price movement after its last earnings report?
Cronos Group reported an EPS of $0.09 in its last earnings report, beating expectations of $0.01. Following the earnings report the stock price went up 12.868%.
Which hedge fund is a major shareholder of Cronos Group?
Currently, no hedge funds are holding shares in CRON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cronos Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.40 (-3.10% Downside)
$3.40 (-3.10% Downside)
Blogger Sentiment
Bullish
CRON Sentiment 86%
Sector Average ―
Sector Average ―
Crowd Wisdom
Positive
Last 7 Days <0.1%
Last 30 Days ▲ 2.2%
Last 30 Days ▲ 2.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.40%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
0.39%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cronos Group
Cronos Group Inc. functions as a diversified global cannabinoid enterprise. Within the United States, it manufactures, promotes, and distributes a variety of hemp-derived supplements and cosmetic products. These items are available under its Lord Jones and Happy Dance brands through online sales, traditional retail, and hospitality partner networks. The company also plays a significant role in the cultivation, production, and commercialization of cannabis and cannabis-infused products for both medicinal and adult-use sectors. Its comprehensive product offerings encompass dried cannabis flower, pre-rolled joints, edibles, concentrated forms, and cannabis extracts. These are distributed via wholesale partnerships and direct-to-consumer channels, prominently featuring its wellness platform, PEACE NATURALS, and its adult-use brand, Spinach. Moreover, Cronos Group exports dried cannabis and cannabis oils to international markets including Germany, Israel, and Australia. Established in 2012, the company maintains its corporate headquarters in Toronto, Canada.
CRON Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a broadly positive operational and financial picture: record revenue, gross profit, and adjusted EBITDA, strong brand performance (notably Spinach), meaningful international growth (Israel and Germany), and a robust cash position. Key risks and headwinds include a new anti-dumping investigation in Israel, modest OpEx increases, margin variability tied to seasonality and mix, and timing uncertainty around the CanAdelaar closing. On balance, the positive operational momentum and strong financials outweigh the highlighted risks.View all CRON earnings summariesCRON Stock 12 Month Forecast
Average Price Target
$3.40
▼(-3.10% Downside)
Technical Analysis
Ownership Overview
4.53% Insiders
0.65% Mutual Funds
― Other Institutional Investors
92.60% Public Companies and
Individual Investors